Kerendia was originally approved in July 2021 to reduce cardiovascular and kidney complications in patients with chronic ...

Leqselvi (deuruxolitinib) 8 mg tablets are approved for adults with severe alopecia areata, a disease that causes the immune system to attack hair follicles, leading to partial or complete hair loss ...